top of page

End-User License Agreement (EULA) and Disclaimers for SignWave

Effective Date: 05-14-2025

​

1. Agreement Overview This End-User License Agreement ("Agreement") is between you ("User") and SuperGenix Inc. DBA Somos Labs, Inc. ("Company"), located at 6021 Milwaukie Ave SE, Portland, OR 97202. By using the SignWave alpha software ("Software"), you accept and agree to this Agreement. This Agreement is governed by Company’s Terms of Service https://www.somosxr.com/terms-of-service and Privacy Policy https://www.somosxr.com/privacy-policy, which are incorporated herein by reference.

​

2. License Company hereby grants User a limited, non-exclusive, non-transferable, non-sublicensable license to use the Software and accompanying materials that describe the operation or specifications of the Software only in connection with the alpha testing phase of the Software.

 

3. Intended Use and Disclaimer The Software provided is an early alpha version for testing purposes only. It is offered strictly as a general exerciser for hand and wrist movements.

 

THE SOFTWARE IS NOT INTENDED FOR THE DIAGNOSIS, TREATMENT, CURE, OR PREVENTION OF ANY MEDICAL CONDITION.

 

No therapeutic or medical claims are made. The Software currently holds no regulatory status and is provided solely "AS IS."

​

4. User Eligibility and Safety Guidelines User must have a Meta account to access and use the Software. User must comply with all applicable Meta Quest platform guidelines [Insert link] including meeting the minimum age requirements specified by Meta Quest platform guidelines. The Software is not available in Iran or China. Users with pre-existing medical conditions, or concerns regarding their ability to safely participate, should consult their healthcare provider before using the Software.

 

Always:

  • Take regular breaks during usage.

  • Avoid overexertion.

  • Immediately discontinue use if experiencing motion sickness, discomfort, or fatigue.

  • Ensure a safe, clear play area.

 

5. Data Collection and Usage Company collects and uses personal information as set forth in its Privacy Policy https://www.somosxr.com/privacy-policy. Company may also collect user feedback through surveys, contact emails, and Meta account emails as provided by Meta App Lab. Collected data will be used as set forth in Company’s Privacy Policy, including without limitation internally for research, product development, and improvement purposes. Anonymized or aggregate data may be shared with third-party clinicians or researchers. All data handling complies with Meta's privacy standards and Company’s Privacy Policy.

​

6. Intellectual Property Rights The Company retains full ownership of all intellectual property rights in the Software and associated content. User participation in this alpha grants no ownership rights to the User.

​

All feedback and suggestions provided by User becomes the exclusive property of the Company and User hereby assigns all rights in such feedback and suggestions to Company.

 

7. Termination of Access The Company reserves the right, at its sole discretion, to terminate User access to the Software at any time for any reason.

​

8. Privacy and Confidentiality The Company complies with its Privacy Policy and adheres to privacy standards set by the Meta platform and will protect user-identifiable data using industry-accepted data handling protocols.

 

9. Warranty Disclaimer User acknowledges that the Software is in the alpha testing phase, and as a result the Software may not function as intended or at all or may include certain defects or bugs. THE SOFTWARE IS PROVIDED "AS IS," WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING, WITHOUT LIMITATION, ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, PERFORMANCE CLAIMS, CLINICAL EFFICACY, OR REGULATORY COMPLIANCE.

​

10. Assumption of Risk User understands and accept that there are inherent risks associated with use of the Software, and that these risks cannot be controlled or eliminated by Company. These include, without limitation, risks associated with falling, overexertion, physical obstacles, defective, broken, or improperly maintained equipment, and the actions and omissions of others. User understands and accepts that use of the Software may result in damage to property and serious injuries resulting in disability, paralysis, or death. User voluntarily agrees to accept all such risks by using the Software, and to be responsible for User’s own health, well-being, and safety.

​

11. Limitation of Liability Under no circumstances will the Company, its affiliates, partners, or licensors be liable for any direct, indirect, incidental, special, consequential, or punitive damages arising out of or relating to the use or inability to use the Software.

 

12. Governing Law and Arbitration This Agreement shall be governed by and construed in accordance with the laws of the State of Oregon, USA. Any disputes arising out of or relating to this Agreement shall be settled exclusively by binding arbitration as set forth in Company’s Terms of Service.

 

13. Contact Information For support or inquiries, contact: 

​

SuperGenix Inc. DBA Somos Labs, Inc.
6021 Milwaukie Ave SE
Portland, OR 97202
Email: support@somosxr.com

bottom of page